Page last updated: 2024-09-03

ru-28362 and neuropeptide y

ru-28362 has been researched along with neuropeptide y in 2 studies

Compound Research Comparison

Studies
(ru-28362)
Trials
(ru-28362)
Recent Studies (post-2010)
(ru-28362)
Studies
(neuropeptide y)
Trials
(neuropeptide y)
Recent Studies (post-2010) (neuropeptide y)
1750310,6631522,269

Protein Interaction Comparison

ProteinTaxonomyru-28362 (IC50)neuropeptide y (IC50)
Neuropeptide Y receptor type 1Homo sapiens (human)0.0014
Neuropeptide Y receptor type 2Homo sapiens (human)0.0003

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akabayashi, A; McEwen, BS; Watanabe, Y1
Dean, RG; Edwards, GL; Martin, RJ; White, BD1

Other Studies

2 other study(ies) available for ru-28362 and neuropeptide y

ArticleYear
Adrenal steroid regulation of neuropeptide Y (NPY) mRNA: differences between dentate hilus and locus coeruleus and arcuate nucleus.
    Brain research. Molecular brain research, 1995, Volume: 28, Issue:1

    Topics: Aldosterone; Androstanols; Animals; Arcuate Nucleus of Hypothalamus; Cerebellar Nuclei; Hippocampus; Locus Coeruleus; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; RNA, Messenger

1995
Type II corticosteroid receptor stimulation increases NPY gene expression in basomedial hypothalamus of rats.
    The American journal of physiology, 1994, Volume: 266, Issue:5 Pt 2

    Topics: Adrenalectomy; Aldosterone; Androstanols; Animals; Blood Glucose; Drug Interactions; Gene Expression Regulation; Hypothalamus, Middle; Infusions, Parenteral; Insulin; Male; Mifepristone; Mineralocorticoid Receptor Antagonists; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Steroid; RNA, Messenger; Spironolactone

1994